Showing 3 results for mortazavi
N Bahaedini, M Atefi, Mj Mortazavi,
Volume 2, Issue 2 (Autumn – Winter 2009[PERSIAN] 2008)
Abstract
Abstract Background and Objectives: Incidents related to electromagnetic interference with medical devices have been reported over the past decades. It has also been indicated that the microwave radiation emitted from mobile phones interferes with the operation of medical devices therefore, this study aimed at testing the interference by GSM mobile phones with cell counters. Material and Methods: We did this experimental Study on thirty-two heparinized blood samples of 32 healthy individuals Selected randomly. The Cell Counting was Carried out in the presence of Electro magnetic field produced by three Cell phones with different levels of SAR (Low, intermediate and High) and without being in electromagnetic field. Statistical tests were used to analyze the data (p<0.05). Results: Microwave radiation emitted from cell phones, regardless of their SAR, interferes with the proper operation of cell Counter. This interference leads to false Counting. Conclusion: As mobile phones emit microwave radiation in an isotropic manner, keeping mobile phones at a safe distance, 15cm, from medical equipments will be necessary. These observations confirm the need for some restrictions of mobile phone use in hospitals and medical laboratories. Key words: Interference, Cell Counters, Mobile Phone, Microwave Radiation
Mahtab Nejadaria, Seyed Mojtaba Mortazavi, Mohammad Hasan Kohansal,
Volume 14, Issue 2 (Mar-Apr 2020)
Abstract
ABSTRACT
Background and Objectives: The pentose phosphate pathway is of particular importance for energy supply in red blood cells. Glucose 6-phosphate dehydrogenase is the key enzyme involved in this pathway. The deficiency of this enzyme due to lack of nicotinamide adenine dinucleotide phosphate (NADPH) production in red blood cells leads to oxidation, hemoglobin deposition, red blood cell membrane changes and favism, which causes jaundice and hemolytic anemia in newborns. In this study, we evaluate the frequency of G6PD deficiency in newborns in a hospital in Bam, Iran.
Methods: In this descriptive-analytical cross-sectional study, blood samples were taken from 572 newborns hospitalized at Pasteur hospital of Bam (Iran) in the first half of 2018. Demographic data including gender and blood type were collected. The G6PD enzyme activity was evaluated using qualitative G6PD assay kit (Saba Teb, Iran). Data were analyzed using SPSS software.
Results: Of the 572 cases examined, 52 (9.09%) had G6PD deficiency. Of the affected patients, 34 (65.4%) were male and 18 (34.6%) were female. In addition, the majority (47.7%) of affected patients were with O+ blood group.
Conclusion: A relatively high frequency of G6PD deficient infants was reported in Bam. As expected, the prevalence of this disorder was higher in males than in females. Given the lost cost of screening, we suggest screening for G6PD enzyme activity in all newborns.
Keywords: Favism, Glucose 6-Phosphate Dehydrogenase, NADPH.
Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Arvin Naeimi, Haniyeh Sadat Fayazi,
Volume 16, Issue 6 (Special issue (Nov-Dec) 2022)
Abstract
Background and objectives: In coronavirus disease 2019 (COVID-19), elevated serum levels of C-reactive protein (CRP), a marker of systemic inflammation, are commonly observed. We aimed to investigate the associations between CRP test results and clinical characteristics in patients with COVID-19.
Method: In this cross-sectional study, data from 399 patients with COVID-19 were collected through a census method. The patients were divided into a CRP-positive group (n=335) and a CRP-negative group (n=64). Demographical data, laboratory findings, clinical characteristics, and history of some underlying diseases were compared between the two groups. All analyses were carried out in SPSS (version 21).
Results: The frequency of hypertension was 40.1% among the study population, 42.4 % among CRP-positive patients, and 28.1% among CRP-negative patients. Diabetes and heart disease were the most common comorbidities among the patients. Dyspnea (60.4%), fever (52.7%), fatigue (45.4%), and dry cough (40.1%) were the most commonly observed symptoms. The mean duration of hospitalization was 8.14±6.18 days, and the mean duration of intensive care unit stay was 9.09±9.41 days. Moreover, CRP positivity was significantly associated with hypertension, immunosuppressive therapy, and higher duration of hospitalization (p<0.05).
Conclusion: Pre-existing hypertension, diabetes, and heart disease with the coincidence of some clinical symptoms are associated with higher levels of CRP in COVID-19 patients, which results in longer hospitalization.
